EUVIMEDEUVIMED entdecken
FallberichtLeserbrief

Successful switching to brodalumab in a patient with severe psoriasis developing ixekizumab-induced eczema

Ryoko Kimura, Kazunari Sugita, Osamu Yamamoto

European Journal of Dermatology · 2020-12 · 30 (6) · 732-734

DOI: 10.1684/ejd.2020.3904 ↗

Kurz gefasst

Fallbericht in der Zeitschrift European Journal of Dermatology, 2020-12. Verfasst von Ryoko Kimura und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Department of Medicine of Sensory and Motor Organs, Tottori University Faculty of Medicine, Yonago 683-8504, Japan. Die Arbeit wurde bisher 14-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgedAntibodies, Monoclonal, HumanizedDermatologic AgentsDrug EruptionsEczemaHumansInterleukin-17MalePsoriasisSeverity of Illness Index

Substanzen

Antibodies, Monoclonal, HumanizedDermatologic AgentsInterleukin-17brodalumabixekizumab

Autor:innen und Institutionen

  • Division of Dermatology, Department of Medicine of Sensory and Motor Organs, Tottori University Faculty of Medicine, Yonago 683-8504, Japan.

Zitieren

APA

Kimura, R., Sugita, K., & Yamamoto, O. (2020). Successful switching to brodalumab in a patient with severe psoriasis developing ixekizumab-induced eczema. European Journal of Dermatology, 30(6), 732-734. https://doi.org/10.1684/ejd.2020.3904

Vancouver

Kimura R, Sugita K, Yamamoto O. Successful switching to brodalumab in a patient with severe psoriasis developing ixekizumab-induced eczema. European Journal of Dermatology. 2020;30(6):732-734. doi:10.1684/ejd.2020.3904

BibTeX
@article{Kimura2020,
  author = {Kimura, Ryoko and Sugita, Kazunari and Yamamoto, Osamu},
  title = {Successful switching to brodalumab in a patient with severe psoriasis developing ixekizumab-induced eczema},
  journal = {European Journal of Dermatology},
  year = {2020},
  volume = {30},
  number = {6},
  pages = {732--734},
  doi = {10.1684/ejd.2020.3904}
}
Kostenlos starten →